학술논문
Regorafenib combined with a PD-1 inhibitor in the second-line setting for unresectable hepatocellular carcinoma in real-world practice
Document Type
Article
Author
Source
In: Journal of Gastrointestinal Oncology . (Journal of Gastrointestinal Oncology, February 2024, 15(1):368-376)
Subject
Language
English
ISSN
2219679X
20786891
20786891